Literature DB >> 20224388

Genetics of lipid disorders.

James Pirruccello1, Sekar Kathiresan.   

Abstract

PURPOSE OF REVIEW: In this review, we will highlight recent advances in identifying genes and gene regions responsible for the variation in serum lipid levels. We will also consider the next directions for research based on these advances. RECENT
FINDINGS: Large-scale genome-wide association studies have successfully screened common variants across the genome for association with serum lipids and have generated novel hypotheses about the causes of serum lipid variation.
SUMMARY: Deep sequencing of genome-wide association signals promises to expand the catalogue of variants responsible for serum lipid variation and, with a full catalogue of variants, we may develop a panel of polymorphisms with clinical utility. In parallel, functional exploration of the genome-wide association signals should expand our knowledge of lipoprotein metabolism and generate targets for pharmacologic intervention.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20224388      PMCID: PMC3928570          DOI: 10.1097/HCO.0b013e328338574d

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  19 in total

1.  A spectrum of PCSK9 alleles contributes to plasma levels of low-density lipoprotein cholesterol.

Authors:  Ingrid K Kotowski; Alexander Pertsemlidis; Amy Luke; Richard S Cooper; Gloria L Vega; Jonathan C Cohen; Helen H Hobbs
Journal:  Am J Hum Genet       Date:  2006-01-20       Impact factor: 11.025

2.  Sequence variations in PCSK9, low LDL, and protection against coronary heart disease.

Authors:  Jonathan C Cohen; Eric Boerwinkle; Thomas H Mosley; Helen H Hobbs
Journal:  N Engl J Med       Date:  2006-03-23       Impact factor: 91.245

3.  Comprehensive whole-genome and candidate gene analysis for response to statin therapy in the Treating to New Targets (TNT) cohort.

Authors:  John F Thompson; Craig L Hyde; Linda S Wood; Sara A Paciga; David A Hinds; David R Cox; G Kees Hovingh; John J P Kastelein
Journal:  Circ Cardiovasc Genet       Date:  2009-02-12

4.  Identification of genetic variants associated with response to statin therapy.

Authors:  Jessica L Mega; David A Morrow; Alison Brown; Christopher P Cannon; Marc S Sabatine
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-08-10       Impact factor: 8.311

5.  Effect of torcetrapib on the progression of coronary atherosclerosis.

Authors:  Steven E Nissen; Jean-Claude Tardif; Stephen J Nicholls; James H Revkin; Charles L Shear; William T Duggan; Witold Ruzyllo; William B Bachinsky; Gabriel P Lasala; Gregory P Lasala; E Murat Tuzcu
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

6.  Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.

Authors:  John J P Kastelein; Sander I van Leuven; Leslie Burgess; Greg W Evans; Jan A Kuivenhoven; Philip J Barter; James H Revkin; Diederick E Grobbee; Ward A Riley; Charles L Shear; William T Duggan; Michiel L Bots
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

7.  Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice.

Authors:  Thomas A Lagace; David E Curtis; Rita Garuti; Markey C McNutt; Sahng Wook Park; Heidi B Prather; Norma N Anderson; Y K Ho; Robert E Hammer; Jay D Horton
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

8.  Mutations in PCSK9 cause autosomal dominant hypercholesterolemia.

Authors:  Marianne Abifadel; Mathilde Varret; Jean-Pierre Rabès; Delphine Allard; Khadija Ouguerram; Martine Devillers; Corinne Cruaud; Suzanne Benjannet; Louise Wickham; Danièle Erlich; Aurélie Derré; Ludovic Villéger; Michel Farnier; Isabel Beucler; Eric Bruckert; Jean Chambaz; Bernard Chanu; Jean-Michel Lecerf; Gerald Luc; Philippe Moulin; Jean Weissenbach; Annick Prat; Michel Krempf; Claudine Junien; Nabil G Seidah; Catherine Boileau
Journal:  Nat Genet       Date:  2003-06       Impact factor: 38.330

9.  Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.

Authors:  Richa Saxena; Benjamin F Voight; Valeriya Lyssenko; Noël P Burtt; Paul I W de Bakker; Hong Chen; Jeffrey J Roix; Sekar Kathiresan; Joel N Hirschhorn; Mark J Daly; Thomas E Hughes; Leif Groop; David Altshuler; Peter Almgren; Jose C Florez; Joanne Meyer; Kristin Ardlie; Kristina Bengtsson Boström; Bo Isomaa; Guillaume Lettre; Ulf Lindblad; Helen N Lyon; Olle Melander; Christopher Newton-Cheh; Peter Nilsson; Marju Orho-Melander; Lennart Råstam; Elizabeth K Speliotes; Marja-Riitta Taskinen; Tiinamaija Tuomi; Candace Guiducci; Anna Berglund; Joyce Carlson; Lauren Gianniny; Rachel Hackett; Liselotte Hall; Johan Holmkvist; Esa Laurila; Marketa Sjögren; Maria Sterner; Aarti Surti; Margareta Svensson; Malin Svensson; Ryan Tewhey; Brendan Blumenstiel; Melissa Parkin; Matthew Defelice; Rachel Barry; Wendy Brodeur; Jody Camarata; Nancy Chia; Mary Fava; John Gibbons; Bob Handsaker; Claire Healy; Kieu Nguyen; Casey Gates; Carrie Sougnez; Diane Gage; Marcia Nizzari; Stacey B Gabriel; Gung-Wei Chirn; Qicheng Ma; Hemang Parikh; Delwood Richardson; Darrell Ricke; Shaun Purcell
Journal:  Science       Date:  2007-04-26       Impact factor: 47.728

10.  Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3.

Authors:  Nina P Paynter; Daniel I Chasman; Julie E Buring; Dov Shiffman; Nancy R Cook; Paul M Ridker
Journal:  Ann Intern Med       Date:  2009-01-20       Impact factor: 25.391

View more
  11 in total

1.  A Simple Scalable Association Hypothesis Test Combining Gene-wide Evidence From Multiple Polymorphisms.

Authors:  Dhananjay Vaidya; Lisa R Yanek; Rasika A Mathias; Taryn F Moy; Diane M Becker; Lewis C Becker
Journal:  Br J Med Med Res       Date:  2014-03

Review 2.  Strategic approaches to unraveling genetic causes of cardiovascular diseases.

Authors:  A J Marian; John Belmont
Journal:  Circ Res       Date:  2011-05-13       Impact factor: 17.367

Review 3.  The enigma of genetics etiology of atherosclerosis in the post-GWAS era.

Authors:  A J Marian
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

Review 4.  Molecular genetic studies of complex phenotypes.

Authors:  Ali J Marian
Journal:  Transl Res       Date:  2011-08-31       Impact factor: 7.012

Review 5.  Medical DNA sequencing.

Authors:  Ali J Marian
Journal:  Curr Opin Cardiol       Date:  2011-05       Impact factor: 2.161

Review 6.  The genetics of obesity and the metabolic syndrome.

Authors:  Keri L Monda; Kari E North; Steven C Hunt; D C Rao; Michael A Province; Aldi T Kraja
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-06       Impact factor: 2.895

Review 7.  Genetic analysis of deep phenotyping projects in common disorders.

Authors:  Elliot S Gershon; Godfrey Pearlson; Matcheri S Keshavan; Carol Tamminga; Brett Clementz; Peter F Buckley; Ney Alliey-Rodriguez; Chunyu Liu; John A Sweeney; Sarah Keedy; Shashwath A Meda; Neeraj Tandon; Rebecca Shafee; Jeffrey R Bishop; Elena I Ivleva
Journal:  Schizophr Res       Date:  2017-10-20       Impact factor: 4.939

Review 8.  Functional link between plasma membrane spatiotemporal dynamics, cancer biology, and dietary membrane-altering agents.

Authors:  Alfredo Erazo-Oliveras; Natividad R Fuentes; Rachel C Wright; Robert S Chapkin
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

9.  SHBG gene polymorphism (rs1799941) associates with metabolic syndrome in children and adolescents.

Authors:  Marquitta J White; Fatih Eren; Deniz Agirbasli; Scott M Williams; Mehmet Agirbasli
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

10.  Interleukin-6 gene polymorphisms, dietary fat intake, obesity and serum lipid concentrations in black and white South African women.

Authors:  Yael T Joffe; Lize van der Merwe; Juliet Evans; Malcolm Collins; Estelle V Lambert; Alison V September; Julia H Goedecke
Journal:  Nutrients       Date:  2014-06-24       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.